Compare Abbott India with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AJANTA PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AJANTA PHARMA ABBOTT INDIA/
AJANTA PHARMA
 
P/E (TTM) x 52.7 28.2 186.8% View Chart
P/BV x 17.0 7.8 217.3% View Chart
Dividend Yield % 0.4 0.4 89.8%  

Financials

 ABBOTT INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
AJANTA PHARMA
Mar-19
ABBOTT INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs8,8341,422 621.3%   
Low Rs5,458898 608.0%   
Sales per share (Unadj.) Rs1,731.1233.5 741.3%  
Earnings per share (Unadj.) Rs211.944.0 482.0%  
Cash flow per share (Unadj.) Rs219.952.2 421.6%  
Dividends per share (Unadj.) Rs65.009.00 722.2%  
Dividend yield (eoy) %0.90.8 117.2%  
Book value per share (Unadj.) Rs945.2255.1 370.6%  
Shares outstanding (eoy) m21.2588.02 24.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.15.0 83.1%   
Avg P/E ratio x33.726.4 127.8%  
P/CF ratio (eoy) x32.522.2 146.1%  
Price / Book Value ratio x7.64.5 166.3%  
Dividend payout %30.720.5 149.8%   
Avg Mkt Cap Rs m151,848102,081 148.8%   
No. of employees `0003.56.8 51.3%   
Total wages/salary Rs m4,3564,307 101.1%   
Avg. sales/employee Rs Th10,555.53,022.6 349.2%   
Avg. wages/employee Rs Th1,249.9633.4 197.3%   
Avg. net profit/employee Rs Th1,292.2569.1 227.1%   
INCOME DATA
Net Sales Rs m36,78620,554 179.0%  
Other income Rs m1,133211 537.4%   
Total revenues Rs m37,91920,765 182.6%   
Gross profit Rs m6,0475,664 106.8%  
Depreciation Rs m169721 23.5%   
Interest Rs m2312 194.0%   
Profit before tax Rs m6,9895,143 135.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4851,273 195.2%   
Profit after tax Rs m4,5033,870 116.4%  
Gross profit margin %16.427.6 59.7%  
Effective tax rate %35.624.8 143.7%   
Net profit margin %12.218.8 65.0%  
BALANCE SHEET DATA
Current assets Rs m27,61011,812 233.7%   
Current liabilities Rs m8,5693,776 226.9%   
Net working cap to sales %51.839.1 132.4%  
Current ratio x3.23.1 103.0%  
Inventory Days Days6077 77.8%  
Debtors Days Days2782 33.6%  
Net fixed assets Rs m1,05714,398 7.3%   
Share capital Rs m213175 121.2%   
"Free" reserves Rs m19,87322,277 89.2%   
Net worth Rs m20,08622,452 89.5%   
Long term debt Rs m07 0.0%   
Total assets Rs m29,40926,962 109.1%  
Interest coverage x311.6444.3 70.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.8 164.1%   
Return on assets %15.414.4 106.9%  
Return on equity %22.417.2 130.1%  
Return on capital %34.923.0 152.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36910,682 3.5%   
Fx outflow Rs m4,9182,102 234.0%   
Net fx Rs m-4,5498,580 -53.0%   
CASH FLOW
From Operations Rs m4,9913,748 133.2%  
From Investments Rs m-2,570-2,228 115.4%  
From Financial Activity Rs m-1,428-1,475 96.8%  
Net Cashflow Rs m99345 2,197.6%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 1.6 509.7%  
FIIs % 0.1 7.6 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.0 100.6%  
Shareholders   18,270 20,968 87.1%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   WYETH  PIRAMAL ENTERPRISES  NATCO PHARMA  NEULAND LABS  IPCA LABS  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 12, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - TORRENT PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS